DJI46,648.83+1.14%
GDAXI23,007.17+1.64%
GSPC6,628.77+1.10%
HSI25,335.95+1.09%
IXIC22,075.27+1.44%
N22553,749.62+2.87%
AAPL254.14+0.99%
AMZN212.58+2.57%
CL87.79-4.94%
EURUSD1.1587-0.22%
GBPUSD1.3389-0.22%
GC4,562.10+3.64%
GOOG294.07+1.68%
JPM296.98+1.55%
META601.58+1.46%
MSFT375.93+0.86%
NVDA179.54+2.47%
TSLA394.13+2.90%
DJI46,648.83+1.14%
GDAXI23,007.17+1.64%
GSPC6,628.77+1.10%
HSI25,335.95+1.09%
IXIC22,075.27+1.44%
N22553,749.62+2.87%
AAPL254.14+0.99%
AMZN212.58+2.57%
CL87.79-4.94%
EURUSD1.1587-0.22%
GBPUSD1.3389-0.22%
GC4,562.10+3.64%
GOOG294.07+1.68%
JPM296.98+1.55%
META601.58+1.46%
MSFT375.93+0.86%
NVDA179.54+2.47%
TSLA394.13+2.90%
DJI46,648.83+1.14%
GDAXI23,007.17+1.64%
GSPC6,628.77+1.10%
HSI25,335.95+1.09%
IXIC22,075.27+1.44%
N22553,749.62+2.87%
AAPL254.14+0.99%
AMZN212.58+2.57%
CL87.79-4.94%
EURUSD1.1587-0.22%
GBPUSD1.3389-0.22%
GC4,562.10+3.64%
GOOG294.07+1.68%
JPM296.98+1.55%
META601.58+1.46%
MSFT375.93+0.86%
NVDA179.54+2.47%
TSLA394.13+2.90%
LIVE
USA Seeking Alpha EN

ProMIS Neurosciences GAAP EPS of -$22.61 misses by $2.57

Mar 25, 2026 &03032525202631; 12:03 UTC seekingalpha.com Trending 2/5
Read original on seekingalpha.com ↗
Negative for markets
Sentiment score: -65/100
Low impact Short-term (days)
WHAT THIS MEANS
ProMIS Neurosciences reported a significant GAAP EPS miss of -$22.61 vs. expected -$20.04, indicating substantial losses and disappointing financial performance. This is a fresh earnings miss on a micro-cap biotech stock with minimal market impact on broad indices.
AI CONFIDENCE
45% Moderate
SENTIMENT GAUGE
NEWS POWER SCORE
AFFECTED ASSETS
PMN
PMNStock
Expected to decline
Fresh earnings miss with EPS of -$22.61 vs. consensus -$20.04; biotech company showing larger-than-expected losses will likely trigger selling pressure in the stock itself, though impact is isolated to this micro-cap name
S&P 500
^GSPCIndex
High volatility expected
S&P 500 already down 0.37% and VIX elevated at 25.45; ProMIS is too small to move broad market, but confirms risk-off sentiment in growth/biotech sectors
PRICE HISTORY
Loading chart...
SUGGESTED ACTION
ProMIS stock likely to gap down at open or experience intraday selling. Avoid chasing shorts on micro-caps with poor liquidity; if trading, wait for stabilization and volume confirmation. Broader market weakness suggests biotech sector rotation may continue. [MOVE:3.5%]
KEY SIGNALS
Fresh earnings miss (6 minutes old)Large negative EPS surprise (-$2.57 miss)Micro-cap biotech with limited liquidityBroader market already showing weakness (-0.37% S&P, elevated VIX)
SECTORS INVOLVED
HealthcareBiotechnology
Analysis generated on Mar 25, 2026 at 12:10 UTC
Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Seeking Alpha. Always conduct your own research and consult a qualified financial advisor before making investment decisions.